BridgeBio Pharma (BBIO) Common Equity (2018 - 2026)
BridgeBio Pharma (BBIO) recorded Common Equity of -$1.66 billion in Q3 2026, compared with -$1.92 billion a year earlier.
Powered by 
Analysis
BridgeBio Pharma (BBIO) Common Equity (2018 - 2026) Analysis & Trends
At the end of FY2025, BridgeBio Pharma reported Common Equity of -$2.09 billion.
- Across earlier years, Common Equity came in at -$1.46 billion in FY2024, -$1.34 billion in FY2023, -$1.24 billion in FY2022 and -$867 million in FY2021.
- The Q3 2026 figure is the highest quarterly Common Equity since Q1 2025.
- Per Business Quant, the preceding three quarters came in at -$2.5 billion (Q2 2026), -$2.27 billion (Q1 2026) and -$2.09 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 89.30 Bn |
| 10 | BridgeBio Pharma | 15.42 Bn | 11.64 Bn | 332.72 Mn | -1.66 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -1.66 Bn |
| Jun 30, 2026 | -2.50 Bn |
| Mar 31, 2026 | -2.27 Bn |
| Dec 31, 2025 | -2.09 Bn |
| Sep 30, 2025 | -1.92 Bn |
| Jun 30, 2025 | -1.78 Bn |
| Mar 31, 2025 | -1.64 Bn |
| Dec 31, 2024 | -1.46 Bn |
| Sep 30, 2024 | -1.22 Bn |
| Jun 30, 2024 | -1.08 Bn |
| Mar 31, 2024 | -1.04 Bn |
| Dec 31, 2023 | -1.34 Bn |
| Sep 30, 2023 | -1.20 Bn |
| Jun 30, 2023 | -1.35 Bn |
| Mar 31, 2023 | -1.21 Bn |
| Dec 31, 2022 | -1.24 Bn |
| Sep 30, 2022 | -1.13 Bn |
| Jun 30, 2022 | -1.01 Bn |
| Mar 31, 2022 | -1.04 Bn |
| Dec 31, 2021 | -867.00 Mn |
API Access
BridgeBio Pharma Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=BBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();